UNSPSC 51284706: Retapamulin

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4MG6O8991R. European Medicines Agency schedules Retapamulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25391. Retapamulin generally arises in the molecular formula C30H47NO4S. The term RETAPAMULIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53.) Most nations schedule retapamulin under HS 29419000 and SITC 54139.

As of Q4 2014, RETAPAMULIN remains the US FDA Preferred Term for this commodity. Retapamulin bears US NLM identifiers UMLS ID C1703334 and NCI Concept Code C61924. SMILES: S(C1CC2N(C(C1)CC2)C)CC(=O)OC1C2(C3C(C(C(O)C(C1)(C)C=C)C)(CCC2C)CCC3=O)C.

UNSPSC 51284706 Retapamulin (Commodity) represents pharmaceutical products procured by state and local health agencies, though recent activity under this specific code is sparse and does not align clearly with the code's nominal scope. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for antibiotics including Doxycycline Hyclate and Ciprofloxacin Hydrochloride—neither of which are retapamulin—suggesting state and local procurement offices may tag multi-product pharmaceutical purchases under broad or adjacent UNSPSC codes rather than drilling to product-level specificity. Seminole County, Florida posted a separate IFB for naloxone and drug deactivation systems, also distinct from retapamulin. State and local health departments appear to be the primary issuing bodies under pharmaceutical commodity codes, often executing purchases through cooperative purchasing consortia such as MMCAP Infuse to access pre-negotiated supplier agreements.

Geographic activity is confined to the records shown: Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 contract over three years (12-month initial term with two renewal options) to Chartwell Rx LLC via Invitation for Bid (IFB) in August 2026, with no set-asides or domestic product preferences applied. Seminole County's July 2026 IFB for naloxone and deactivation systems (1,900 units and 800 units annually, respectively) required quarterly deliveries with a two-year initial term and one-year renewal option, though that notice shows a due date of July 26, 2023, indicating potential dating inconsistency in the source. The scarcity of recent opportunities explicitly coded to retapamulin and the mismatch between the code name and actual products awarded suggest limited or irregular state and local procurement activity under this specific commodity classification.